|
|
|
26.03.26 - 14:48
|
Trading by management and close relations of management (GlobeNewswire EN)
|
|
|
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
|
|
|
|
|
23.03.26 - 13:57
|
Trading by management and close relations of management (GlobeNewswire EN)
|
|
|
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
|
|
|
|
|
13.03.26 - 10:00
|
Novonesis issues EUR 1.7 billion senior unsecured notes (GlobeNewswire EN)
|
|
|
On March 12, 2026, Novonesis, through Novozymes A/S, successfully priced and closed an aggregate principal amount of EUR 1.7 billion senior unsecured notes (the "Notes"). The issuance was completed under the newly established EUR 4 billion Euro Medium Term Note (EMTN) Programme, dated March 10, 2026....
|
|
|
11.03.26 - 13:42
|
Trading by management and close relations of management (GlobeNewswire EN)
|
|
|
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
|
|
|
09.03.26 - 22:36
|
Novonesis named a Great Employer to Work For in North Carolina (GlobeNewswire EN)
|
|
|
Franklinton, North Carolina, March 09, 2026 (GLOBE NEWSWIRE) -- Novonesis, a global leader in biosolutions, has been named a 2026 Great Employer to Work for in North Carolina by Best Companies Group (BCG), marking the company's first time earning this prestigious recognition. BCG is a trusted leader in workplace culture research and recognition, distinguishing top companies around the United States for more than 20 years. The honor is based entirely on confidential employee feedback and a comprehensive evaluation of workplace practices, culture, and leadership. ...
|
|
|
27.02.26 - 10:27
|
Trading by management and close relations of management (GlobeNewswire EN)
|
|
|
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
|
|
|
26.02.26 - 17:06
|
Trading by management and close relations of management (GlobeNewswire EN)
|
|
|
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
|
|
|
26.02.26 - 12:03
|
Invitation to the 2026 Annual General Meeting (GlobeNewswire EN)
|
|
|
The Annual General Meeting of Novonesis (Novozymes A/S) will be held on Monday March 23, 2026 at 4:00 pm CET at Gammel Venlighedsvej 14, DK-2970 Hoersholm, Denmark. There will also be access to the meeting from the entrance at Boege Alle 10-12, DK-2970 Hoersholm, Denmark....
|
|
|
26.02.26 - 11:27
|
Trading by management and close relations of management (GlobeNewswire EN)
|
|
|
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
|
|
|
26.02.26 - 06:12
|
Novozymes Reports Climb In Q4 Bottom Line (AFX)
|
|
|
BRUSSELS (dpa-AFX) - Novozymes (NVZMF.PK) reported earnings for its fourth quarter that Increases, from the same period last yearThe company's earnings came in at EUR122.8 million, or EUR1.25 per ......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06.11.25 - 12:36
|
AI, Cost Cuts Drive Most US Layoffs In October Since 2003 | The Pulse 11/6 (Bloomberg)
|
|
|
"The Pulse With Francine Lacqua" is all about conversations with high profile guests in the beating heart of global business, economics, finance and politics. Based in London, we go wherever the story is, bringing you exclusive interviews and market-moving scoops.
Today's guests: Estelle Brachlianoff, Veolia CEO; Jari Stehn, Goldman Sachs; Ester Baiget, Novonesis President & CEO (Source: Bloomberg)...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
